As President & CEO of Rady Children’s Institute for Genomic Medicine, Dr Stephen Kingsmore plays a key role in driving access to diagnostic whole genome sequencing (WGS) services for children with symptoms of genetic disease. In this Q&A with Will Greene, Healthcare Engagement Lead for Roche Diagnostics Asia Pacific, Dr Kingsmore discusses how the institute provides […]
As the founding president of Indus Hospital & Health Network (IHHN), Dr Abdul Bari Khan oversees an important organisation that provides free healthcare to the people of Pakistan. In this Q&A with Mr Abdul Qayyum, Country Manager (Pakistan and Afghanistan) at Roche Diagnostics Asia Pacific, he discusses the history, mission and unique operating model of
Bringing free healthcare to Pakistan: Q&A with Dr Abdul Bari Khan Read More »
Dr Phil Reilly is a physician, clinical geneticist, biotech entrepreneur, venture capitalist and author with deep experience in rare disease diagnostics, including newborn screening (NBS). In this Q&A with Will Greene, Healthcare Engagement Manager and Project Strongbow Co-Lead at Roche Diagnostics Asia Pacific, we learn more about the history and future of NBS technologies in
Dr Phil Reilly on newborn screening: past, present and future Read More »
As CEO of P.D. Hinduja Hospital & Medical Research Centre, Gautam Khanna leads one of the premier private hospitals in India. In this Q&A with Narendra Varde, General Manager of Roche Diagnostics India & Neighbouring Markets, we learn more about Khanna’s unique approach to leadership, views on the value of laboratory diagnostics, and hopes for
Hospital management excellence in India: Q&A with Mr Gautam Khanna Read More »
In 2019, Dr Thomas Grogan published Chasing the Invisible, a memoir about his experience in launching, scaling and selling Ventana Medical Systems, a pioneer and leading provider of automated instruments for tissue diagnosis. In the third instalment of this three-part series on Dr Grogan’s life and career, we explore some of the key lessons from
After launching Ventana Medical Systems as a spinout from the University of Arizona, Dr Thomas Grogan played a central role in building the company from a scrappy startup into a leading provider of automated instruments for tissue biopsies and cancer diagnostics. In the second instalment of this three-part series on Dr Grogan’s life and career,
Scaling and selling a tissue diagnostics startup: Q&A with Dr Thomas Grogan (Part 2) Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
